1[3]DeAbate CA, Mclvor RA, Elvaine P, et al. Gatifloxacin vs cefuroxime axetil in patients with acute exacerbations of chronic bronchitis[J]. J Respir Dis, 1999, 20(11 Suppl):S23.
2[4]Ramirez A, Molina J, Holmann A, et al. Gatifloxacin treatment in patients with acute exacerbations of chronic bronchitis clinical trial results [J]. J Respir Dis, 1999, 20(11 Suppl): S30.
3[5]Ball P, Wilson R, Mardell A, et al. Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised,double-blind comparison with trovaf1oxacin [J]. J Chemother, 2001,13(3) :288.
4[6]Adelglass J, Jones TM, Ruoff G, et al. A multicenter,investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis [J]. Pharmacotherapy, 1998, 18 (6):1255.
5[7]Menzies D, Klein NC, Cunha BA. Trovafloxacin neurotoxicity[J]. Am J Med, 1999, 107(3): 298.
6[9]Lieu PK, Tok SC, Ismail NH, et al. Ciprofloxacin-induced cutaneous vasculitis[J]. Allergy, 1997, 52(5): 593.
7[10]Ferguson J, McEwen J, A1-Ajmi H, et al. A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects [J]. J Antimicrob Chemother, 2000, 45(4): 503.
8[11]Ksuajima H, Ishida R, Uchida H. Phototoxicity of gatifloxacin, a new quinolone, and its related drugs in guinea pigs[J]. Jpn Pharmacol Ther, 1998, 26(10): 1655.
9[12]Ferguson J, McEwen J, Gobler K, et al. Phototoxic potential of gatifloxacin, a new fluoroquinolone antimicrobial [J]. Drugs, 1999, 58(Suppl 2): S397.
10[13]Vousden M, Ferguson J, Richards J, et al. Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin [J]. Chemotherapy, 1999, 45(6) : 512.
